Zimbabwe still reports a 85% in the pregnant women living with hiv antiretroviral therapy coverage for pmtct, unchanged since 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Zimbabwe
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Zimbabwe
PMTCT antiretroviral therapy coverage
More indicators for Zimbabwe
Male unintentional poisoning
4.3
-0.3
(2019)
Female wasting in children
2.8%
-0.5%
(2019)
Female prevalence of HIV
4.4%
-0.3%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar6
+intl dollar0
(2021)
Birth registration
48.7%
+10.7%
(2019)
Contraceptive modern method prevalence
65.8%
-0.7%
(2015)
Zimbabwe PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | PMTCT antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 85% | 0% |
| 2021 | 85% | -3% |
| 2020 | 88% | -6% |
| 2019 | 94% | +2% |
| 2018 | 92% | +2% |
| 2017 | 90% | +3% |
| 2016 | 87% | +6% |
| 2015 | 81% | 0% |
| 2014 | 81% | +6% |
| 2013 | 75% | 0% |
| 2012 | 75% | +27% |
| 2011 | 48% | +18% |
| 2010 | 30% | -15% |
| 2009 | 45% | +8% |
| 2008 | 37% | +14% |
| 2007 | 23% | +9% |
| 2006 | 14% | +2% |
| 2005 | 12% | +4% |
| 2004 | 8% | -1% |
| 2003 | 9% | +7% |
| 2002 | 2% | +2% |
| 2001 | 0% | 0% |
| 2000 | 0% |